tiprankstipranks
Advertisement
Advertisement
Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
PremiumRatingsMilestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
21d ago
Midday Fly By: FedEx reports ‘beat and raise,’ Ecolab to acquire CoolIT
Premium
The Fly
Midday Fly By: FedEx reports ‘beat and raise,’ Ecolab to acquire CoolIT
21d ago
Milestone Advances CARDAMYST Launch After Landmark PSVT Approval and Bolsters Cash Runway
Premium
Company Announcements
Milestone Advances CARDAMYST Launch After Landmark PSVT Approval and Bolsters Cash Runway
21d ago
Milestone Pharmaceuticals to present Cardamyst data at ACC 26
PremiumThe FlyMilestone Pharmaceuticals to present Cardamyst data at ACC 26
25d ago
Milestone Pharmaceuticals Sets March 20 Call for 2025 Results and Business Update
Premium
Company Announcements
Milestone Pharmaceuticals Sets March 20 Call for 2025 Results and Business Update
29d ago
Milestone Pharmaceuticals appoints Sandoval as General Counsel, CCO
Premium
The Fly
Milestone Pharmaceuticals appoints Sandoval as General Counsel, CCO
2M ago
Milestone Pharmaceuticals: Undervalued CARDAMYST Opportunity with EU Upside and Strong Risk‑Reward Supporting Buy Rating
PremiumRatingsMilestone Pharmaceuticals: Undervalued CARDAMYST Opportunity with EU Upside and Strong Risk‑Reward Supporting Buy Rating
3M ago
Milestone’s PSVT nasal spray MAA accepted by EMA
Premium
Company Announcements
Milestone’s PSVT nasal spray MAA accepted by EMA
3M ago
Milestone announces acceptance of MAA by EMA for etripamil nasal spray
Premium
The Fly
Milestone announces acceptance of MAA by EMA for etripamil nasal spray
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100